Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
News (2023)
24 March, 2023
Community participation critical to SWEEP TB out of Daru
An ambitious new project that aims to screen, test and treat all residents of Daru for tuberculosis has begun.
24 March, 2023
New treatment guidelines for drug-resistant TB
New WHO guidelines have a ‘revolutionary potential’ to expand access to treatments for drug-resistant tuberculosis.
24 March, 2023
COVID derailed tuberculosis progress and urgent action is needed
Professor Brendan Crabb and Results Australia CEO Negaya Chorley on how lessons from the global COVID-19 response could be applied to defeat tuberculosis.
21 March, 2023
Why don’t most viruses make bats sick?
Bats carry a lot of viruses that make humans and other mammals very sick, but don’t make them sick. Here’s what we currently understand about why that is.
21 March, 2023
Strong partnerships key to continued RID-TB program success
The RID-TB project was able to continue operating throughout the COVID-19 pandemic and is now back to full strength.
14 March, 2023
Extension for project tackling antimicrobial resistance in PNG
A major project tackling antimicrobial resistance in Papua New Guinea has been extended until December 2023.
10 March, 2023
Three years into the pandemic, it’s clear COVID won’t fix itself. Here’s what we need to focus on next
Burnet Institute Director and CEO Professor Brendan Crabb AC and Associate Principal Research Fellow, Professor Mike Toole AO write for The Conversation.
08 March, 2023
Myanmar people and health system show resilience during double crises
The Myanmar people and health system have shown resilience during the double crises of the COVID-19 pandemic and political crisis, new research has found.
07 March, 2023
Burnet supports decision to make Richmond’s supervised injecting facility permanent
Burnet Institute welcomes the Victorian government’s decision to make the North Richmond Medically Supervised Injecting Room an ongoing service.
03 March, 2023
Two-pronged approach to target critical malaria protein
A protein that plays a critical role in helping malaria parasites infect red blood cells has been found to bind to more than one receptor on the surface of the cells.
01 March, 2023
Participating in research can be beneficial for people who inject drugs
A new study has found participating in research over many years can give people who inject drugs a chance to share their experiences and contribute to broader knowledge.
23 February, 2023
Burnet welcomes announcement of regional health investment package
Burnet Institute has welcomed the Australian government’s announcement of an investment package that aims to help build a stronger and more resilient Asia-Pacific.
20 February, 2023
Australia’s long COVID problem needs to be acknowledged
Australia needs to acknowledge the significant long COVID problem we are facing, Burnet Director and CEO Professor Brendan Crabb told a public hearing this morning.
16 February, 2023
International podcast award for How Science Matters
The acclaimed podcast series ‘How Science Matters’ has won a prestigious international award for specialist content marketing agency Written & Recorded and Burnet Institute.
09 February, 2023
Reducing the overdose rate for people who inject drugs after they’re released from prison
The rate of non-fatal opioid overdoses following release from prison is far higher than previously estimated, new Burnet Institute research has revealed.
08 February, 2023
Women need to be better represented on Australian clinical practice guideline panels
Women have been under-represented on Australian clinical practice guideline panels, new analysis from Burnet Institute reveals.
01 February, 2023
Twice as many Victorians may have had COVID-19 in January 2022 than reported, new analysis reveals
New analysis has revealed twice as many Victorians may have had COVID-19 during the Omicron BA.1 wave in January 2022 than reported numbers.
26 January, 2023
Health leaders support call for COVID strategy rethink
Australian public health leaders have supported calls from Burnet Director and CEO Professor Brendan Crabb for a reset on COVID-19 management policy.
26 January, 2023
Australia Day honour for Dame Carol Kidu
Dame Carol Kidu DBE and the late Professor George Patton are among eminent Australians with close ties to Burnet, acknowledged in 2023 Australia Day Honours.
25 January, 2023
Professor Caroline Homer a research world leader
Burnet’s Professor Caroline Homer has been acknowledged for her global leadership in the field of pregnancy and childbirth by The Australian newspaper.
24 January, 2023
IMPACT Summer 2023
See our strategy in action. Discover how we’re working towards a healthier world for all people.
24 January, 2023
Scaling up naloxone access to save lives
Burnet Institute welcomes and supports the national rollout of Take Home Naloxone (THN) in Australia.
24 January, 2023
How Burnet’s Papua New Guinea team has responded to the challenges of COVID-19
Our Papua New Guinea (PNG) team has been an integral part of the pandemic response in the region, working closely with communities and our partners.
24 January, 2023
VOICE: Building on pandemic lessons and community strengths
The VOICE project will build on good practices forged during the pandemic and better connect Victoria’s multicultural communities with the services they need.
24 January, 2023
Building confidence and dispelling stigma around sexual and reproductive health
Adolescents and young people in Myanmar have been empowered with the knowledge and communication skills to talk more openly about puberty and the changes they go through.
24 January, 2023
A visit to Burnet starts a family’s 35-year relationship with the Institute
Peter Cleary remembers the event that started his connection with Burnet Institute.
24 January, 2023
On the road to 2030: breaking down the entrenched barrier to hepatitis C elimination
Australia can eliminate hepatitis C as a public health threat by 2030 but needs more than just the availability of direct-acting antivirals (DAA).
19 January, 2023
Pregnancies don’t stop during a pandemic: how a lack of information about COVID-19 impacted pregnant Australians
Pregnant women wanted more timely information during the early years of the COVID-19 pandemic in Australia, new research has found.
18 January, 2023
China’s COVID cases may have hit 900 million. What’s headed our way?
With international travel to and from China resuming, it’s inevitable the virus will spread to other countries, Professor Mike Toole writes for The Conversation.
17 January, 2023
Optimise Study deemed success in directly informing Victoria’s COVID-19 response
The success of the Optimise Study in shaping Victoria’s and Australia’s response to the COVID-19 pandemic paves the way for similarly ambitious research projects in the future.
17 January, 2023
Lack of quality data an obstacle to reducing stillbirths in the Pacific, UN report reveals
A United Nations report has revealed 86 per cent of countries in the Pacific have no quality data on stillbirths, complicating efforts to reduce the burden of stillbirth in the region.
16 January, 2023
Access to DAAs linked to fall in hep C incidence
A new collaborative Burnet-led study links broad access to direct acting antiviral treatments to a decline in the incidence of hepatitis C.
02 January, 2023
COVID exploits our year of living dangerously
Professor Brendan Crabb and Professor Mike Toole on the need for Australia to adopt an anti-transmission strategy to control COVID-19.
